Uropathogenic Escherichia coli - Escherichia coli: Pathotypes and Principles of Pathogenesis - page 294

Vigil, P.D., Stapleton, A.E., Johnson, J.R., et al., 2011b. Presence of putative repeat-in-toxin gene
tosA in Escherichia coli predicts successful colonization of the urinary tract. MBio 2 (3),
e00066-e00011 .
Vigil, P.D., Wiles, T.J., Engstrom, M.D., Prasov, L., Mulvey, M.A., Mobley, H.L., 2012. The repeat-
in-toxin family member TosA mediates adherence of uropathogenic Escherichia coli and sur-
vival during bacteremia. Infect. Immun. 80 (2), 493-505 .
Virkola, R., Westerlund, B., Holthofer, H., Parkkinen, J., Kekomaki, M., Korhonen, T.K., 1988.
Binding characteristics of Escherichia coli adhesins in human urinary bladder. Infect. Immun.
56 (10), 2615-2622 .
Visvikis, O., Boyer, L., Torrino, S., et al., 2011. Escherichia coli producing CNF1 toxin hijacks
Tollip to trigger Rac1-dependent cell invasion. Trafic 12 (5), 579-590 .
Walters, M.S., Lane, M.C., Vigil, P.D., Smith, S.N., Walk, S.T., Mobley, H.L., 2012. Kinetics of
uropathogenic Escherichia coli metapopulation movement during urinary tract infection. MBio
3 (1) .
Wang, H., Liang, F.X., Kong, X.P., 2008. Characteristics of the phagocytic cup induced by uro-
pathogenic Escherichia coli . J. Histochem. Cytochem. 56 (6), 597-604 .
Welch, R.A., 1991. Pore-forming cytolysins of gram-negative bacteria. Mol. Microbiol. 5 (3),
521-528 .
Welch, R.A., Burland, V., Plunkett 3rd, G., et al., 2002. Extensive mosaic structure revealed by the
complete genome sequence of uropathogenic Escherichia coli . Proc. Natl. Acad. Sci. USA 99
(26), 17020-17024 .
Welch, R.A., Forestier, C., Lobo, A., Pellett, S., Thomas Jr., W., Rowe, G., 1992. The synthesis
and function of the Escherichia coli hemolysin and related RTX exotoxins. FEMS Microbiol.
Immunol. 5 (1-3), 29-36 .
Westerlund, B., Kuusela, P., Risteli, J., et al., 1989. The O75X adhesin of uropathogenic Escherichia
coli is a type IV collagen-binding protein. Mol. Microbiol. 3 (3), 329-337 .
Wright, K.J., Seed, P.C., Hultgren, S.J., 2005. Uropathogenic Escherichia coli lagella aid in
efficient urinary tract colonization. Infect. Immun. 73 (11), 7657-7668 .
Wu, X.R., Kong, X.P., Pellicer, A., Kreibich, G., Sun, T.T., 2009. Uroplakins in urothelial biology,
function, and disease. Kidney Int. 75 (11), 1153-1165 .
Xia, Y., Gally, D., Forsman-Semb, K., Uhlin, B.E., 2000. Regulatory cross-talk between adhesin
operons in Escherichia coli : inhibition of type 1 imbriae expression by the PapB protein.
EMBO J. 19 (7), 1450-1457 .
Yadav, M., Zhang, J., Fischer, H., et al., 2010. Inhibition of TIR domain signaling by TcpC:
MyD88-dependent and independent effects on Escherichia coli virulence. PLoS Pathog. 6 (9),
e1001120 .
Yamamoto, S., Tsukamoto, T., Terai, A., Kurazono, H., Takeda, Y., Yoshida, O., 1995. Distribu-
tion of virulence factors in Escherichia coli isolated from urine of cystitis patients. Microbiol.
Immunol. 39 (6), 401-404 .
Yokota, T., Gots, J.S., 1970. Requirement of adenosine 3 ′ , 5′-cyclic phosphate for lagella formation
in Escherichia coli and Salmonella typhimurium . J. Bacteriol. 103 (2), 513-516 .
Zalewska, B., Piatek, R., Cieslinski, H., Nowicki, B., Kur, J., 2001. Cloning, expression, and purii-
cation of the uropathogenic Escherichia coli invasin DraD. Protein Expr. Purif. 23 (3), 476-482 .
Zhou, G., Mo, W.J., Sebbel, P., et al., 2001. Uroplakin Ia is the urothelial receptor for uropathogenic
Escherichia coli : evidence from in vitro FimH binding. J. Cell. Sci. 114 (Pt 22), 4095-4103 .